tiprankstipranks
Trending News
More News >

Medifast Stockholders Approve Key Proposals at Annual Meeting

Story Highlights
Medifast Stockholders Approve Key Proposals at Annual Meeting

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Medifast ( (MED) ).

On June 18, 2025, Medifast held its Annual Meeting where stockholders voted on several proposals. All directors nominated for re-election were successfully re-elected to the Board. The stockholders also ratified the appointment of RSM US LLP as the Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025. Additionally, the compensation of the company’s named executive officers was approved on an advisory basis, and the Amended 2012 Plan was also approved.

The most recent analyst rating on (MED) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Medifast stock, see the MED Stock Forecast page.

Spark’s Take on MED Stock

According to Spark, TipRanks’ AI Analyst, MED is a Neutral.

Medifast’s overall stock score reflects significant financial and operational challenges, including declining revenue and negative earnings, despite a strong balance sheet and cash reserves. Technical analysis shows mixed signals, while valuation metrics suggest overvaluation given the current operational losses. The recent earnings call reveals both strategic efforts and ongoing difficulties.

To see Spark’s full report on MED stock, click here.

More about Medifast

Average Trading Volume: 231,524

Technical Sentiment Signal: Sell

Current Market Cap: $155.7M

See more data about MED stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1